Company: LRHC
Filing Date: 2025-09-25
Form Type: S-1
Source: 0001213900-25-091637
Chunk: 31

Company: La Rosa Holdings Corp.
Filing Date: 2025-09-25
Form: S-1
Chunk 31
---
 stock outstanding, and therefore the Exchange Cap is 244,805 shares of common stock. the
Selling Stockholder will not be required to subscribe for any shares of common stock under the Facility which, when aggregated with all
other shares of common stock then beneficially owned by the Selling Stockholder and its affiliates (as calculated pursuant to Section
13(d) of the Exchange Act, and Rule 13d-3 promulgated thereunder), would result in the beneficial ownership by the Selling Stockholder
and its affiliates to exceed 4.99% (which the Selling Stockholder, upon notice to the Company, may increase or decrease but in no event
in excess of 9.99%) of the outstanding voting power or number of the common stock.

If, following satisfaction of the conditions set
forth in the Facility, we elect to sell to the Selling Stockholder all of Shares being registered for resale hereunder, depending on the
market prices of our common stock at the time of such sales, the gross proceeds from such sales of all such shares of common stock by
us to the Selling Stockholder may be substantially less than the $1,000,000,000 total purchase commitment available to us under the Facility,
which could materially adversely affect our liquidity.

If it becomes necessary for us to issue and sell
to the Selling Stockholder shares of common stock in excess of the Exchange Cap under the Facility in order to receive additional gross
proceeds up to $1,000,000,000 under the Facility, then for so long as the Exchange Cap continues to apply to the issuances and sales of
our common stock under the Facility, we must first obtain stockholder approval to issue shares of common stock in excess of the Exchange
Cap in accordance with the applicable Nasdaq listing rules. Any issuance and sale by us under the Facility of shares of common stock in
excess of the Exchange Cap could cause additional substantial dilution to our stockholders. The number of shares of our common stock ultimately
offered for sale by the Selling Stockholder is dependent upon the number of shares of common stock, if any, we ultimately sell to the
Selling Stockholder under the Facility, and the sale of common stock under the Facility may cause the trading price of our common stock
to decline.

Investors who buy shares at different times will likely pay different prices, and the sale of the shares of common stock acquired by the Selling Stockholder could cause the price of our common stock to decline.

Pursuant